1. Home
  2. SPRY vs NWN Comparison

SPRY vs NWN Comparison

Compare SPRY & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPRY
  • NWN
  • Stock Information
  • Founded
  • SPRY 2015
  • NWN 1859
  • Country
  • SPRY United States
  • NWN United States
  • Employees
  • SPRY N/A
  • NWN N/A
  • Industry
  • SPRY Biotechnology: Pharmaceutical Preparations
  • NWN Oil/Gas Transmission
  • Sector
  • SPRY Health Care
  • NWN Utilities
  • Exchange
  • SPRY Nasdaq
  • NWN Nasdaq
  • Market Cap
  • SPRY 1.8B
  • NWN 1.6B
  • IPO Year
  • SPRY N/A
  • NWN N/A
  • Fundamental
  • Price
  • SPRY $11.62
  • NWN $41.53
  • Analyst Decision
  • SPRY Strong Buy
  • NWN Buy
  • Analyst Count
  • SPRY 4
  • NWN 2
  • Target Price
  • SPRY $28.75
  • NWN $48.00
  • AVG Volume (30 Days)
  • SPRY 2.3M
  • NWN 260.1K
  • Earning Date
  • SPRY 08-13-2025
  • NWN 08-05-2025
  • Dividend Yield
  • SPRY N/A
  • NWN 4.72%
  • EPS Growth
  • SPRY N/A
  • NWN 17.48
  • EPS
  • SPRY N/A
  • NWN 2.58
  • Revenue
  • SPRY $112,339,000.00
  • NWN $1,238,288,000.00
  • Revenue This Year
  • SPRY N/A
  • NWN $17.95
  • Revenue Next Year
  • SPRY $182.40
  • NWN $5.66
  • P/E Ratio
  • SPRY N/A
  • NWN $16.10
  • Revenue Growth
  • SPRY 22367.80
  • NWN 8.40
  • 52 Week Low
  • SPRY $10.00
  • NWN $38.03
  • 52 Week High
  • SPRY $18.90
  • NWN $44.38
  • Technical
  • Relative Strength Index (RSI)
  • SPRY 25.12
  • NWN 55.93
  • Support Level
  • SPRY $13.32
  • NWN $40.84
  • Resistance Level
  • SPRY $14.00
  • NWN $41.60
  • Average True Range (ATR)
  • SPRY 1.00
  • NWN 0.63
  • MACD
  • SPRY -0.30
  • NWN 0.11
  • Stochastic Oscillator
  • SPRY 9.88
  • NWN 71.20

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

About NWN Northwest Natural Holding Company

Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in one reportable business segment, which is NW Natural's local gas distribution business and is referred to as the NGD segment. The company generates its revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.

Share on Social Networks: